American journal of ophthalmology
Reply to Comment on Glucagon-Like Peptide-1 Receptor Agonist Use and Risk of Cataract Development.
Abhimanyu S Ahuja, Alfredo A Paredes Iii, Sejal A Ahuja, Benjamin K Young
Published: 202510.1016/j.ajo.2025.12.021
No abstract available for this study.